Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Langmuir : the ACS Journal of Surfaces and Colloids|August 12, 2024
Graphene Incorporated Sugar Derived Carbon Aerogel for Pyridine Adsorption and Oil-Water SeparationFaguni Agrawal, Kiran Gupta, Jaidev Kaushik, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 1, 2017
Impact of Warfarin Persistence on Health-Care Utilization and Costs Among Patients With Atrial Fibrillation Managed in Anticoagulation Clinics in the United StatesSteven B Deitelzweig, Michael Evans, Jeffrey Trocio, et al.BMC Cardiovascular Disorders|June 15, 2019
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense populationKiran Gupta, Jeffrey Trocio, Allison Keshishian, et al.Journal of Medical Economics|June 13, 2017
Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world settingJay Lin, Jeffrey Trocio, Kiran Gupta, et al.International Journal of Biological Macromolecules|November 12, 2017
Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: Pharmacokinetic and teratogenic assessmentSanjay Kumar Singh, Mahendra Kumar Hidau, Shrikant Gautam, et al.Current Medical Research and Opinion|August 30, 2017
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patientsSteven Deitelzweig, Xuemei Luo, Kiran Gupta, et al.The American Journal of Managed Care|October 18, 2019
Real-world outcomes among patients with early rapidly progressive rheumatoid arthritisAndrew J Klink, Tammy G Curtice, Kiran Gupta, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial FibrillationSteven Deitelzweig, Xuemei Luo, Kiran Gupta, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 25, 2018
All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral AnticoagulantsSteve Deitelzweig, Xuemei Luo, Kiran Gupta, et al.Journal of Managed Care & Specialty Pharmacy|September 14, 2018
Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense PopulationKiran Gupta, Jeffrey Trocio, Allison Keshishian, et al.Pageof 7